JB Chemicals Shareholders Approve Amalgamation with Torrent Pharma at NCLT Meeting

JB Chemicals & Pharmaceuticals Ltd. ( (IN:JBCHEPHARM) ) has provided an update.

JB Chemicals & Pharmaceuticals Ltd. informed the stock exchange that it held a National Company Law Tribunal (NCLT) convened meeting of its equity shareholders on April 28, 2026 via video conferencing. The meeting was properly constituted with the requisite quorum and chaired by Mahesh Gupta.

At the meeting, shareholders approved the proposed Scheme of Amalgamation of JB Chemicals & Pharmaceuticals Ltd. with Torrent Pharmaceuticals Ltd., meeting the statutory requirement of a majority in number and three-fourths in value of equity shareholders voting through remote e-voting and e-voting during the meeting. The company said detailed voting results and the scrutinizer’s report will be disclosed separately to the stock exchanges in line with regulatory requirements.

More about JB Chemicals & Pharmaceuticals Ltd.

JB Chemicals & Pharmaceuticals Ltd. is an Indian pharmaceutical company engaged in the manufacture and marketing of formulations and active pharmaceutical ingredients, with a focus on branded generics and specialty therapies. Its equity shares are listed on Indian stock exchanges, and it operates within a highly regulated healthcare and pharmaceutical market.

Average Trading Volume: 11,863

Technical Sentiment Signal: Strong Buy

Current Market Cap: 321.8B INR

For a thorough assessment of JBCHEPHARM stock, go to TipRanks’ Stock Analysis page.